1 - 15 of 27 Results Clear All
The new research center will accelerate cures for the world’s gravest cancers
Institutional News News Release Cancer Marson Lab
Alex Marson, MD, PhD, director of the Gladstone-UCSF Institute of Genomic Immunology, comments on breakthrough technology developed in his lab that will greatly facilitate the large-scale engineering of immune cells for cell-based therapies.
Gladstone Experts Genomic Immunology Marson Lab CRISPR/Gene Editing
Scientists develop a new approach that produces enough cells for therapeutic applications
News Release Research (Publication) Genomic Immunology Esensten Lab Eyquem Lab Marson Lab CRISPR/Gene Editing
A Gene Not Previously Known to Regulate Immunity Could Turn Tired T-Cells Around
News Release Research (Publication) Cancer Genomic Immunology Carnevale Lab Marson Lab
The new immune networks have implications for developing immunotherapies and understanding autoimmune diseases
News Release Research (Publication) Autoimmune Diseases Genomic Immunology Marson Lab
The new study paves the way toward more effective cancer immunotherapies
News Release Cancer Genomic Immunology Marson Lab
Fierce Biotech—Alexander Marson, director of the Gladstone-UCSF Institute of Genomic Immunology, and his colleagues at UC San Francisco and the Salk Institute for Biological Studies, recently showed that obese mice with atopic dermatitis had an altered immune response that made them refractory to anti-inflammatory treatment. Fierce Biotech discusses the implications of this finding for the development of drugs against inflammation and asthma.
Gladstone Experts Genomic Immunology Marson Lab Disease Models
A new catalog to help better understand how HIV hijacks human cells
Research (Publication) HIV/AIDS Data Science and Biotechnology Genomic Immunology Virology Krogan Lab Marson Lab
STAT News—Alexander Marson, director of the Gladstone-UCSF Institute of Genomic Immunology, describes new research from his group showing that the immune response in a mouse model of atopic dermatitis is altered by obesity. This difference rendered first-line therapies ineffective in mice, indicating that treatments for inflammatory disorders may need to be tailored to work in individual patients, depending on their metabolic state.
Gladstone Experts Genomic Immunology Marson Lab Disease Models Metabolism
Researchers have discovered why immune treatments for allergies and asthma might not be as effective in obese mice and humans
News Release Research (Publication) Genomic Immunology Marson Lab
Researchers adapt a variation of the CRISPR-Cas9 system to activate genes in human immune cells and study the consequences
News Release Research (Publication) Genomic Immunology Marson Lab CRISPR/Gene Editing
Watch recordings from the Gladstone-UCSF Institute of Genomic Immunology Symposium
Gladstone Experts Genomic Immunology Marson Lab Pelka Lab Genomics
Born in Cuba, Rosmely Hernandez explains how her grandfather’s battle with Parkinson’s disease sparked her desire to pursue a career in science
Graduate Students and Postdocs Profile Marson Lab
Unable to return to his home country during the COVID-19 surge in India, a Gladstone postdoc took to YouTube to share useful information about the virus and how to stay protected
Gladstone Experts Graduate Students and Postdocs COVID-19 Marson Lab
Gladstone researchers fine-tuned CRISPR-Cas9 genome editing to work on human immune cells called monocytes
News Release Research (Publication) Data Science and Biotechnology Genomic Immunology Krogan Lab Marson Lab CRISPR/Gene Editing
